The type II sodium-dependent phosphate co-transporters Npt2a and Npt2c play critical roles in the reabsorption of P i by renal proximal tubular cells. The vitamin A metabolite ATRA (all-trans-retinoic acid) is important for development, cell proliferation and differentiation, and bone formation. It has been reported that ATRA increases the rate of P i transport in renal proximal tubular cells. However, the molecular mechanism is still unknown. In the present study, we observed the effects of a VAD (vitamin A-deficient) diet on P i homoeostasis and the expression of Npt2a and Npt2c genes in rat kidney. There was no change in the plasma levels of P i , but VAD rats significantly increased renal P i excretion. Renal brush-border membrane P i uptake activity and renal Npt2a and Npt2c expressions were significantly decreased in VAD rats. The transcriptional activity of a luciferase reporter plasmid containing the promoter region of human Npt2a and Npt2c genes was increased markedly by ATRA and a RAR (retinoic acid receptor)-specific analogue TTNPB {4- [E-2-(5,6,7,8-tetrahydro-5,5,8,8-tetra-methyl-2-naphtalenyl)-1-propenyl] benzoic acid} in renal proximal tubular cells overexpressing RARs and RXRs (retinoid X receptors). Furthermore, we identified RAREs (retinoic acidresponse elements) in both gene promoters. Interestingly, the halfsite sequences (5 -GGTTCA-3 : − 563 to − 558) of 2c-RARE1 overlapped the vitamin D-responsive element in the human Npt2c gene and were functionally important motifs for transcriptional regulation of human Npt2c by ATRA and 1,25(OH) 2 D 3 (1α,25-dihydroxyvitamin D 3 ), in both independent or additive actions. In summary, we conclude that VAD induces hyperphosphaturia through the down-regulation of Npt2a and Npt2c gene expression in the kidney.
INTRODUCTION
P i plays a critical role in skeletal development, mineral metabolism, and diverse cellular functions involving intermediary metabolism and energy-transfer mechanisms [1, 2] . The serum P i level is maintained within a narrow range through a complex interplay between intestinal absorption, exchange with intracellular and bone storage pools, and renal tubular reabsorption [1, 2] . The crucial regulated step in P i homoeostasis is the transport of P i in the brush-border membrane of the renal proximal tubule. P i transport is mediated by several Npts (sodium-dependent phosphate co-transporters), which have been classified in three categories: type I (Npt1), type II (Npt2a and Npt2c) and type III (PiT1 and PiT2) [1, 2] .
Npt1 is not regulated by dietary P i . In fact, studies in Npt1-cRNA-injected oocytes have revealed that it may also function as a channel for Cl − and organic anions [3, 4] . PiT1 and PiT2 are ubiquitously expressed and serve housekeeping functions [5] . However, it has been reported that PiT2 is expressed in the apical membrane of renal proximal tubules, is regulated by dietary P i and may contribute to the phosphaturia of dietary potassium deficiency [6, 7] . Npt2a and Npt2c are responsible for most of the P i reabsorption in the kidney [8, 9] . Npt2c was originally identified as a growth-related P i transporter expressed in the kidney [10] . Although Npt2c has been reported to play only a minor role in renal phosphate reuptake in rodents, defects in this gene have recently been reported to underlie HHRH (hereditary hypophosphatemic rickets with hypercalciuria) [11, 12] . This suggests that both Npt2a and Npt2c are important in renal reabsorption of phosphate. Npt2a and Npt2c are strictly regulated by dietary P i and P i -regulating hormones such as PTH (parathyroid hormone), 1,25(OH) 2 D 3 (1α,25-dihydroxyvitamin D 3 ) and FGF23 (fibroblast growth factor 23) [3, 10, [13] [14] [15] [16] [17] [18] . Recently, we discovered that thyroid hormones regulate P i homoeostasis through transcriptional control of the renal Npt2a gene [19] . However, the mechanisms that regulate P i homoeostasis, including the roles of Npt2a and Npt2c, have not been fully elucidated and the presence of other P i -regulating factors can be assumed.
ATRA (all-trans-retinoic acid), a metabolite of vitamin A, stimulates P i uptake in OK (opossum kidney) cells, a process regulated by a genomic mechanism [20] . Furthermore, there are Abbreviations used: ATRA, all-trans-retinoic acid; BBMV, brush-border membrane vesicle; β-gal, β-galactosidase; Cr, creatinine; 1,25(OH) 2 D 3 , 1α,25-dihydroxyvitamin D 3 ; DR, direct repeat; EMSA, electrophoretic mobility-shift assay; FBS, fetal bovine serum; FEI, fractional excretion index; FGF23, fibroblast growth factor 23; Npt, sodium-dependent phosphate co-transporter; NF-κB, nuclear factor κB; OK cell, opossum kidney cell; PTH, parathyroid hormone; RAR, retinoic acid receptor; RARE, retinoic acid-responsive element; RXR, retinoid X receptor; TTNPB, 4-[E-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphtalenyl)-1-propenyl] benzoic acid; VAD, vitamin A-deficient; VDR, vitamin D receptor; VDRE, vitamin D-responsive element. 1 These authors contributed equally to this work. 2 To whom correspondence should be addressed (email yamamoto@nutr.med.tokushima-u.ac.jp).
several reports about the effects of vitamin A on the metabolism of P i and calcium in rats [21] [22] [23] . However, the effects of ATRA on renal P i homoeostasis and the expression of Npt2a and Npt2c in kidney remain unclear, both in vitro and in vivo. ATRA plays an important role in the development and differentiation of epithelial tissues and immunity [24] [25] [26] . The physiological actions of retinoids are mediated by specific nuclear receptors, such as RARs (retinoic acid receptors) and RXRs (retinoid X receptors). These receptors are members of the steroid/thyroid hormone nuclear receptor superfamily and act as ligand-dependent transcriptional factors. RARs and RXRs regulate the transcription of target genes by binding to RAREs (retinoic acid-response elements) composed typically of two DRs (direct repeats) of a core hexameric motif, PuG(G/T)TCA in their promoters [27, 28] . The classical RARE is a 5-bp-spaced DR (DR-5), but RAR-RXR heterodimers also bind to DRs separated by 1 bp (DR-1) or 2 bp (DR-2). RXRs also bind to DR-1 as RXR-RXR homodimers [29] .
In the present study, we have used VAD (vitamin A-deficient) rats to determine the effects of vitamin A on the expression of Npt2a and Npt2c in kidney. We also characterized the promoter of human Npt2a and Npt2c genes with regard to transcriptional regulation through RARs.
MATERIALS AND METHODS

VAD animals
Male Wistar rats (3 weeks old, 30-50 g) were purchased from Japan SLC (Shizuoka, Japan). All rats were randomly divided into two groups and housed in metal cages at 22
• C with a 12 h light/12 h dark cycle and given free access to food and drinking water. The control group was fed on an altered AIN93-G diet (Oriental Yeast, Osaka, Japan) containing 0.6 % P i and 0.6 % Ca 2+ , whereas the VAD group was fed on an altered vitamin A-deficient AIN-93G diet (Oriental Yeast) containing 0.6 % P i and 0.6 % Ca 2+ for 7 weeks. Both groups of rats fasted for 24 h in metabolic cages with water ad libitum before being killed and tissue extraction. Composition of the diets is shown in Supplementary Table S1 (at http://www.BiochemJ.org/bj/429/bj4290583add.htm). Rats were maintained under pathogen-free conditions and handled in accordance with the Guidelines for Animal Experimentation of the Tokushima University School of Medicine.
Plasma and urine parameters
Concentrations of P i , Ca 2+ and Cr (creatinine) were determined as described previously [9] . Concentrations of plasma vitamin A (retinol) were determined by HPLC assays (Mitsubishi Chemical Medience, Tokyo, Japan). Concentrations of plasma 1,25(OH) 2 D, PTH and FGF23 were determined as described previously [9] . Metabolic cages were used for 24 h urine collection. The FEIs (fractional excretion indexes) for P i (FEI P i ) and for Ca 2+ (FEI Ca 2+ ) were calculated as urine P i or Ca 2+ /(urine Cr × plasma P i or Ca 2+ ).
Preparation of BBMVs (brush-border membrane vesicles) and P i uptake
BBMVs were prepared from rat kidney by the Ca 2+ precipitation method as described previously [30] . The uptake of 32 P into BBMVs was measured by a rapid filtration technique. Vesicle suspension (10 μl) was added to 90 μl of incubation solution (100 mM NaCl, 100 mM mannitol, 20 mM Hepes/Tris, and 0.1 mM KH 2 32 PO 4 , pH 7.5), and the preparation was incubated at 20
• C. Sodium-dependent P i uptake was measured as described previously [30] .
Western blot analysis
Protein samples were heated at 95
• C for 5 min in sample buffer in the presence of 5 % 2-mercaptoethanol and subjected to SDS/PAGE. The separated proteins were transferred by electrophoresis on to PVDF (Immobilon-P, Millipore). The membranes were treated with diluted anti-Npt2a antibody (1:5000) and antiNpt2c antibody (1:500). Mouse anti-actin monoclonal antibody (Sigma) was used as an internal control. Goat anti-rabbit IgG(H + L)-horseradish peroxidase conjugate (Bio-Rad) was utilized as the secondary antibody, and signals were detected using the ECL Plus system (GE Healthcare).
Quantitative PCR analysis
Extraction of total RNA, cDNA synthesis and real-time PCR were performed as described previously [19] . The primer sequences for PCR amplification are shown in Supplementary Table S2 (at http://www.BiochemJ.org/bj/429/bj4290583add.htm). Amplification products were then analysed by a melting curve, which confirmed the presence of a single PCR product in all reactions (apart from negative controls). The PCR products were quantified by fit-point analysis, and results were normalized to that of β-actin.
Reporter plasmid construction
Luciferase reporter plasmids pNp2a-2.4k and pNp2a-600 were described previously [31] . Reporter plasmids pNp2a-1.8k, pNp2a-1008, pNp2a-800 and pNp2c-900 were constructed by PCR amplification of pNp2a-2.4k or human genomic DNA as the template using gene-specific primers (see Supplementary  Table S3 at http://www.BiochemJ.org/bj/429/bj4290583add.htm). These PCR products were subcloned into a pGL-2 or pGL-3 vector (Promega). Mutated reporter plasmids pNp2a-1.8k-Mut (Mut-A), pNp2c-900-Mut1 (Mut-C1), pNp2c-900-Mut2 (Mut-C2) and pNp2c-900-Mut3 (Mut-C3) were constructed with the QuikChange ® site-directed mutagenesis kit (Stratagene) using the oligonucleotides shown in Supplementary Table S3 . Reporter plasmids pNp2c-600, pNp2c-400, pNp2c-150 and pNp2c + 14 were cloned by the digestion of pNp2c-900 using NheI, SmaI, KpnI, SacI and BglII restriction enzymes respectively. The β-gal (β-galactosidase) expression vector pCMV-β (Clontech) was used as an internal control. Each plasmid was purified with the PureYield TM Plasmid Midiprep System (Promega).
Transfection and luciferase assay
OK-P cells were a gift from Dr Judith A. Cole (Department of Biology, University of Memphis, Memphis, TN, U.S.A.). OK-P cells were cultured as described previously [19] . Mouse RARα, RARβ and RARγ expression vectors, pSG5-RARα, pSG5-RARβ and pSG5-RARγ respectively, and mouse RXRα expression vector pSG5-RXRα were provided by Dr P. Chambon an additional 16 h. The normalized transfection efficiency for luciferase activity was determined by co-transfecting with 0.2 μg of the β-gal expression vector pCMV-β (Stratagene). Cells were harvested in a lysis buffer supplied with the Pica-gene luciferase assay kit (Toyo Ink, Tokyo, Japan) and the lysates were assayed for luciferase activity and β-gal activity.
Extraction of nuclear protein
Nuclear extracts were prepared according to a mini-extraction protocol with minor modifications [32] . Briefly, cells were cultured on 35-mm dishes to 90 % confluence and transfected with pSG5-RARβ and pSG5-RXRα. After washing, cells were harvested by scraping into ice-cold PBS and collected by centrifugation at 500 g for 5 min. Cells were lysed with buffer A (10 mM Hepes, pH 7.9, containing 10 mM KCl, 0.1 mM EDTA, 0.5 % Nonidet P40, 1 mM dithiothreitol and 0.5 mM PMSF) on ice for 20 min and then centrifuged at 14 000 g for 15 min at 4
• C. The nuclear pellets were washed three times with buffer A and resuspended in buffer C (20 mM Hepes, pH 7.9, 0.5 M KCl, 1 mM EDTA, 1 mM dithiothreitol and 1 mM PMSF) for 30 min at 4
• C on a rotating wheel and then centrifuged at 14 000 g for 15 min at 4
• C.
Coupled transcription/translation assays
Each RARβ and the RXRα proteins were synthesized with the TNT ® Quick Coupled Transcription/Translation System (Promega) at 30
• C for 90 min in the presence of 20 μM methionine. Generated proteins were used for EMSAs (electrophoretic mobility-shift assays).
EMSAs
EMSAs were performed as described previously [30] . Doublestranded nucleotides for 2a-RARE (2a), 2a-M, 2c-RARE1 (2c-1), 2c-M1, 2c-RARE2 (2c-2) and 2c-M2 were synthesized (see Supplementary Table S4 at http://www.BiochemJ.org/ bj/429/bj4290583add.htm). Purified DNA fragments were radiolabelled with [γ -32 P]ATP (110 TBq/mmol; ICN, Costa Mesa, CA, U.S.A.) using T 4 polynucleotide kinase (Takara, Shiga, Japan). Prepared nuclear protein and the in vitro translated protein (15 μg and 2 μl respectively) were incubated with the radiolabelled probe in binding buffer [10 mM Tris/HCl, pH 7.5, 1 mM dithiothreitol, 1 mM EDTA, 10 % glycerol, 1 mM MgCl 2 , 0.25 mg/ml BSA, 2.5 μg/ml salmon sperm DNA and 2 μg poly(dI-dC) · (dI-dC) (GE Healthcare)] in a final volume of 20 μl for 30 min at room temperature (20 • C). Specificity of the binding reaction was determined with a 100-fold molar excess of the indicated cold competitor oligonucleotide. DR-5 and NF-κB (nuclear factor κB) consensus oligonucleotides were purchased from Santa Cruz Biotechnology (catalogue numbers sc-2559 and sc-2505 respectively). RAR components of protein-DNA complexes were analysed using a RARβ-specific antibody (sc-552, Santa Cruz Biotechnology). The reaction mixture was then subjected to electrophoresis on a 5 % polyacrylamide gel with 0.25 × TBE running buffer for 2 h at 150 V. The gel was dried and analysed with a Fujix Bio-imaging analyser (BAS-1500, Fujifilm, Tokyo, Japan).
Statistical analysis
Data are expressed as means + − S.E.M. Results were analysed for statistical significance using an unpaired Student's t test. P < 0.05 was considered statistically significant. 
RESULTS
Plasma and urine parameters in VAD rats
Plasma retinol levels were significantly decreased in VAD rats (15.6 + − 2.59 μg/dl) compared with control rats (50.3 + − 1.78 μg/dl, P < 0.001). Although plasma P i and Ca 2+ levels did not differ between VAD and control rats, the urine P i /Cr ratio (but not the Ca 2+ /Cr ratio) was significantly increased in VAD rats compared with controls ( Effects of VAD diets on P i uptake and the expression of the Npt2 gene in rat kidney P i uptake activity in renal BBMVs was significantly decreased in VAD rats compared with control rats ( Figure 1A ). Western blot analysis revealed that expression of both Npt2a and Npt2c proteins was markedly decreased in VAD rats compared with controls ( Figure 1B ). In contrast, there was no difference in Npt1 protein expression between the groups (results not shown). Next, we performed real-time PCR analysis to measure renal Npt2a and Npt2c mRNA expression. Figure 1(C) shows that renal Npt2a and Npt2c mRNA levels were significantly decreased in VAD rats compared with control rats. However, mRNA levels of renal Npt1, PiT1 and PiT2 did not change between the two groups [VAD (relative mRNA levels compared with control 100 %) compared with control; Npt1: 116 + − 7.4 compared with 100 + − 4.6; PiT1: 113 + − 11.9 compared with 100 + − 7.0; PiT2: 91 + − 12.4 compared with 100 + − 7.3; n = 6-7].
Transcriptional regulation of human Npt2a and Npt2c gene promoters by ATRA
We previously identified the human Npt2a gene, and characterized its promoter contained within a 2.4-kb region 5 of exon 1 [31] (Figure 2A ). In the present study, we have now determined that the 1751-bp sequence in 5 of exon 1 and intron 1 of the human Npt2c gene (GenBank ® accession number AB546724) also contains a number of possible binding sites for regulatory proteins (Supplementary Figure S1 at http://www.BiochemJ.org/bj/ 429/bj4290583add.htm). To understand the molecular mechanisms behind the regulation of Npt2a and Npt2c gene expression by vitamin A, we examined the responsiveness of human Npt2a and Npt2c gene promoters to ATRA by luciferase assay. The pNp2a-2.4k reporter construct containing the promoter, exon 1 fragments of the human Npt2a gene, and the pNp2c-900 reporter construct, which contained the promoter, exon 1, intron 1 and exon 2 fragments of the human Npt2c gene, were utilized in OK-P cells. ATRA stimulated the transcriptional activity of both reporter constructs in OK-P cells expressing RARα and RARβ, but not in OK-P cells expressing RARγ (Figures 2A and 2B) . It has been reported that TTNPB is a RAR-specific agonist and has greater affinity for RARs than ATRA [33] . Figures 2(C) and 2(D) illustrate that the promoter activities of human Npt2a and Npt2c genes were increased by ATRA or TTNPB in a dose-dependent fashion and the stimulating activity of TTNPB on the human Npt2a and Npt2c gene promoters was approx. 10-fold greater than that of ATRA.
Deletion analysis of human Npt2a and Npt2c gene promoters
In order to understand the molecular mechanisms underlying the responsiveness of human Npt2a and Npt2c genes to ATRA, several reporter constructs lacking portions of the 5 -promoter region of human Npt2a and Npt2c genes were tested in OK-P cells expressing RAR and RXR, with or without ATRA. Reporter constructs, pNp2a-2.4k, pNp2a-1.8k and pNp2a-1008 markedly increased luciferase activity 4-8-fold in response to ATRA, whereas pNp2a-800 and pNp2a-600 exhibited little increase ( Figure 3A ). These data suggested that the sequence from − 1008 to − 800 is important for ATRA-dependent activation of the human Npt2a gene promoter in OK-P cells. In deletion analysis of the human Npt2c gene promoter, pNp2c-900 and pNp2c-600 increased luciferase activity 3-fold in response to ATRA but pNp2c-400 increased less than 2-fold. In contrast, pNp2c-150 and pNp2c + 14 exhibited no increase ( Figure 3B ). These data suggest that the sequence from − 600 to − 150 is important for ATRA-dependent activation of the human Npt2c gene promoter in OK-P cells.
Identification of the RAREs in the Npt2a and Npt2c gene promoters
We previously reported the sequence of the 5 flanking region and the identification of the VDRE (vitamin D-responsive element) in the human Npt2a gene [30] . The sequences of the RAREs in human Npt2a (2a-RARE: − 855 to − 839) and Npt2c (2c-RARE1: − 578 to − 558 and 2c-RARE2: − 338 to − 322) genes are shown in Figure 4 (A). Although both 2a-RARE and 2c-RARE2 had a 5-nt spacer, 2c-RARE1 had an uncommon 6-nt spacer. We further investigated 2a-RARE, 2c-RARE1 and 2c-RARE2 by EMSA with various oligonucleotides as probes and competitors. As shown in Figure 4 (B), a radiolabelled consensus DR-5 oligonucleotide probe detected a band in protein extracts prepared from OK-P cells overexpressing RARβ and RXRα. These complexes were susceptible to competition with unlabelled DR-5, 2a-RARE (2a), 2c-RARE1 (2c-1) and 2c-RARE2 (2c-2) ( Figure 4B ), but not with mutated probes (2a-M, 2c-M1 and 2c-M2) (see Figure 4A ). The NF-κB oligonucleotide, used as a non-specific competitor, showed no inhibition. Similar results were also obtained in another competition experiment using a radiolabelled oligonucleotide containing 2a-RARE, 2c-RARE1 and 2c-RARE2, with in vitro synthesized RARβ and RXRα. As for 2a-RARE, the formation of this complex with the RAR-RXR heterodimer was inhibited in the presence of unlabelled 2a-RARE and DR5, but not unlabelled 2a-M. In addition, an antibody against RARβ inhibited complex formation with 2a-RARE ( Figure 4C ). Likewise, two oligonucleotides containing 2c-RARE1 and 2c-RARE2 also formed a complex, which was inhibited in the presence of unlabelled 2c-RARE1, 2c-RARE2 and DR5, but not 2c-M1 and 2c-M2. Furthermore, an antibody against RARβ inhibited complex formation with 2c-RARE1 and 2c-RARE2 ( Figure 4D ).
To test further whether 2a-RARE, 2c-RARE1 and 2c-RARE2 sequences were the target sequence of the candidate RARE, we determined the luciferase activity of pNp2a-1.8k-Mut (Mut-A), pNp2c-900-Mut1 (Mut-C1), pNp2c-900-Mut2 (Mut-C2) and pNp2c-900-Mut3 (Mut-C3), whose sequences and constructs are indicated in Figures 4(A) and 5(A). Figure 5 (B) showed that 2a-RARE was essential for activation of the Npt2a gene promoter by ATRA, and 2c-RARE1 was more important for the Npt2c gene promoter to respond to ATRA compared with 2c-RARE2.
Additive actions of ATRA and 1,25(OH) 2 D 3 on the transcriptional regulation of the human Npt2c gene
The existence of a consensus VDRE (− 549 to − 563) in the human Npt2c gene promoter has been reported previously [34] . Interestingly, the half-site sequences (5 -GGTTCA-3 : − 563 to − 558) of 2c-RARE1 overlapped the VDRE in the human Npt2c gene as described above. Therefore we examined the responsiveness of the human Npt2c gene promoter to ATRA and/or 1,25(OH) 2 D 3 in OK-P cells overexpressing RAR and/or VDR (vitamin D receptor) and RXR. In Figure 6 (B), ATRA and 1,25(OH) 2 D 3 stimulated the transcriptional activity of the human Npt2c gene. Moreover, the two ligands exhibited additive action on the transcriptional regulation of the human Npt2c gene. In addition, Mut-C1, as described in Figure 5 (B), abrogated the ability to respond to 1,25(OH) 2 D 3 in a dose-dependent manner compared with pNp2c-900 ( Figure 6C) .
DISCUSSION
In the present study, we have determined that renal P i uptake activity and renal Npt2a and Npt2c expression are decreased in VAD rats and that the transcriptional activity of human Npt2a and Npt2c genes are up-regulated by ATRA and its receptors. VAD rats showed decreased plasma retinol levels and increased urinary P i excretion compared with control rats, but showed no change in plasma P i levels (Table 1) . A similar observation was made by Webb et al. [35] , who showed that vitamin A-deprived sheep Transcriptional activity of deletion constructs of human Npt2a and human Npt2c gene promoters in OK-P cells. Deletion constructs were generated by PCR amplification or restriction enzyme digestion as described in the Materials and methods section and are illustrated on the left-hand side of (A) and (B). The RAREs are shown as black boxes. Either pNp2a-2.4k, pSG5-RARβ (A) or pNp2c-900, pSG5-RARα (B) was transfected with pSG5-RXRα and pCMV-β into OK-P cells. Cells were treated with vehicle (NT, ethanol) or 100 nM ATRA in 10 % FBS-supplemented medium, and cell lysates were assessed for β-gal and luciferase activities 16 h later. Each point represents the average of quadruplicate analysis + − S.E.M. normalized for β-gal activity. Similar results were obtained for three independent experiments. *P < 0.001, **P < 0.0001 compared with NT.
significantly increased urinary P i excretion without affecting plasma P i levels. Indeed, VAD rats showed a decrease in renal P i and both renal Npt2a and Npt2c mRNA and protein levels compared with controls ( Figure 1) . Recently, Villa-Bellosta et al. [6] reported that PiT2 is expressed in the apical membrane of rat renal proximal tubules and is regulated by dietary P i . Breusegem et al. [7] reported that renal Npt2c and PiT2 might contribute to the phosphaturia of dietary potassium deficiency. However, there was no difference in Npt1, PiT1 and PiT2 mRNA expression in the two rat groups (results not shown). These results suggest that VAD induces hyperphosphaturia through down-regulated expression of Npt2a and Npt2c genes in the kidney. It is now unclear why VAD did not alter plasma P i levels despite inducing hyperphosphaturia. In an effort to explain these data, we analysed urinary deoxypryridinoline excretion, a bone resorption marker. However, urinary deoxypyridinoline excretion was not changed (results not shown). Because it has been recently reported that Npt2b plays a critical role in intestinal P i absorption and contributes to the maintenance of systemic P i homoeostasis [36] , further study is necessary to understand whether intestinal P i uptake activity and Npt2b expression are affected by VAD.
Renal P i reabsorption is regulated by a variety of P i -regulating hormones, 1,25(OH) 2 D 3 , PTH and FGF23 [14-17,28 ]. The effects of vitamin A on plasma 1,25(OH) 2 D 3 and PTH, but not plasma FGF23 levels, have been previously investigated [22, 23] . In the results from the present study, the levels of these hormones in VAD rats did not change compared with control rats. These observations suggest that VAD-mediated down-regulation of Npt2a and Npt2c gene expression was independent of plasma 1,25(OH) 2 D 3 , PTH and FGF23 levels ( Figures 1B and 1C) . In the past, it was reported that ATRA stimulates P i uptake through the regulation of a genomic mechanism in OK cells [20] . Therefore we hypothesized that ATRA might increase the expression of Npt2a and Npt2c through regulated transcription.
We previously isolated human Npt2a, mouse Npt2a and mouse Npt2c genes [13, 31, 37] , characterized their promoters, and identified the VDRE in the human Npt2a gene [30] . In the present study, we identified the sequence 5 upstream of exon 1 and intron 1 in the human Npt2c gene. In addition, to understand the molecular mechanism by which ATRA or TTNPB (the RAR-specific analogue) modulated human Npt2a and Npt2c gene promoters, luciferase assays were performed in OK-P cells overexpressing RARβ and RXRα. The transcriptional activities of the two gene promoters were increased by ATRA or TTNPB in a dose-dependent manner (Figure 2) .
The results shown in Figure 5 indicated that all of the RAREs we identified in these genes were essential. Barthel et al. [34] reported the existence of a consensus VDRE in the human Npt2c gene on the basis of in silico analysis. Interestingly, unlike 2a-RARE and 2c-RARE2, 2c-RARE1 had an uncommon 6-nt spacer and the half-site sequences (5 -GGTTCA-3 : − 563 to − 558) of 2c-RARE1 overlapped the VDRE in the human Npt2c gene as described above ( Figure 6A ). Both ATRA and 1,25(OH) 2 D 3 are fat-soluble vitamins and require RXR protein to function as a partner in heterodimer formation for transcriptional action. For example, in vitro and in vivo studies have variously indicated antagonistic, additive or synergistic interactions between these vitamins [38] [39] [40] . In the present study, we showed that ATRA and 1,25(OH) 2 D 3 exhibited additive action on the transcriptional regulation of the human Npt2c gene ( Figure 6B ). In mutation analysis, Mut-C1 abrogated the ability to respond to not only ATRA but also 1,25(OH) 2 D 3 compared with WT-C ( Figures 5D  and 6C ). These results suggested that the overlapped half-site sequences (5 -GGTTCA-3 ) of both 2c-RARE1 and VDRE were supply the sufficient P i required for development and growth in humans.
In summary, we have revealed that vitamin A regulates the renal expression of Npt2a and Npt2c genes in rats. Furthermore, the transcriptional mechanisms by which RAR-and RXRregulated human Npt2a and Npt2c gene promoters were clarified in proximal tubular cells. It is now clear that ATRA regulates renal P i homoeostasis through transcriptional control of Npt2a and Npt2c genes. Npt2a  NM_013030  5 -TCCTCGTCAAGATGCTCAAC-3  5 -CAAAGTAGCCTGTGACCCAA-3  Npt2c  NM_139338  5 -GTTCCACCCCAGGCTTAGAG-3  5 -GAGGAAGCCGCTGACCAC-3  Npt1  NM_133554  5 -TCCCACCAGCTGCACAAGTCG-3  5 -GCCTCGTTCCAAGGGAGGTGC-3  PiT1  NM_031148  5 -CCCATCAGCACAACACATTG-3  5 -TAGGGACGGTGACAAACCAG-3  PiT2 NM_017223 5 -CTGCAAGTCCTCACTGCCTG-3 5 -CTTCTTGTGTAACTCCGCCTTG-3 β-actin NM_031144 5 -CTAAGGCCAACCGTGAAAAGA-3 5 -TGGTACGACCAGAGGCATACA-3 
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